NewsBenzingaギリアド・サイエンシズ、PBCにおけるLivdelziの第3相IDEAL試験成功を報告:52週時点でALP正常化達成率75.4%、プラセボ16.1%。重篤な有害事象はLivdelziで3.1%、プラセボで12.9%、いずれも薬剤関連なし ギリアド・サイエンシズ、PBCにおけるLivdelziの第3相IDEAL試験成功を報告:52週時点でALP正常化達成率75.4%、プラセボ16.1%。重篤な有害事象はLivdelziで3.1%、プラセボで12.9%、いずれも薬剤関連なし Benzinga 2026.11.05 15:05 (GMT+0) Open on Benzinga Other news Rep. Byron Donalds Sells Netflix Stock for Loss: Here’s What He’s Buying Instead StoneX Group Q4 EPS $0.66 Down From $0.70 YoY, Sales $1.461B Up From $1.202B YoY QUICK SPARK: Intel Stock Eyes Worst Two-Month Drop on Record After Triple-Digit Rally Red Robin Gourmet Burgers Q3 Adj. EPS $(0.54) Misses $(0.40) Estimate, Sales $232.098M Miss $252.090M Estimate WesBanco Raises Quarterly Cash Dividend From $0.38 To $0.39 Per Share Universal Technical Expects More Than $1B Revenue And Nearly $150M Adjusted EBITDA In FY28; Sees Revenue Exceeding $1.2B And EBITDA Approaching $220M By Fiscal 2029
Red Robin Gourmet Burgers Q3 Adj. EPS $(0.54) Misses $(0.40) Estimate, Sales $232.098M Miss $252.090M Estimate
Universal Technical Expects More Than $1B Revenue And Nearly $150M Adjusted EBITDA In FY28; Sees Revenue Exceeding $1.2B And EBITDA Approaching $220M By Fiscal 2029